150 related articles for article (PubMed ID: 3296615)
1. [Comparison of 3 therapeutic regimens in paucibacillary leprosy. Preliminary note].
Husser JA; Baquillon G; Pattyn SR
Acta Leprol; 1986; 4(4):447-52. PubMed ID: 3296615
[TBL] [Abstract][Full Text] [Related]
2. [Histological progression of paucibacillary leprosy during treatment with various therapeutic regimens].
Pattyn SR; Husser JA; Janssens L; Nollet E
Acta Leprol; 1986; 4(4):501-4. PubMed ID: 3296623
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
Pattyn SR; Husser JA; Baquillon G; Maiga M; Jamet P
Lepr Rev; 1990 Jun; 61(2):151-6. PubMed ID: 2198414
[TBL] [Abstract][Full Text] [Related]
5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
6. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
7. [Inadequate treatment in multibacillary leprosy and incubation times for relapses].
Pattyn SR; Husser JA; Janssens L; Grillone S; Bourland J
Acta Leprol; 1986; 4(4):495-9. PubMed ID: 3296622
[TBL] [Abstract][Full Text] [Related]
8. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH
Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612
[TBL] [Abstract][Full Text] [Related]
9. Multidrug therapy in paucibacillary leprosy--a five year experience.
Grugni A; Nadkarni NJ; Kini MS
Indian J Lepr; 1988 Oct; 60(4):589-92. PubMed ID: 3253339
[TBL] [Abstract][Full Text] [Related]
10. Short course treatment of paucibacillary (TT/BT) leprosy cases.
Girdhar BK; Girdhar A; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(3):491-8. PubMed ID: 3831086
[TBL] [Abstract][Full Text] [Related]
11. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
Katoch K; Ramanathan U; Natrajan M; Bagga AK; Bhatia AS; Saxena RK; Ramu G
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):458-64. PubMed ID: 2746075
[TBL] [Abstract][Full Text] [Related]
12. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
Kumar B; Kaur S; Kaur I
Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
[TBL] [Abstract][Full Text] [Related]
14. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
[No Abstract] [Full Text] [Related]
15. Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months.
Pattyn SR; Groenen G; Janssens L; Deverchin J; Ghys P
Lepr Rev; 1989 Jun; 60(2):118-23. PubMed ID: 2671560
[TBL] [Abstract][Full Text] [Related]
16. Relapse rate in paucibacillary leprosy patients after multidrug therapy in North Arcot District.
Ekambaram V; Rao MK
Indian J Lepr; 1991; 63(1):34-42. PubMed ID: 1919088
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial with rifampicin in the treatment of leprosy (final report).
Ghosh S; Hazra SK; Kundu S; Choudhury S
Lepr India; 1977 Jul; 49(3):339-43. PubMed ID: 338983
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
Pattyn SR; André PS; Ferracci C; Baquillon G
Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):297-303. PubMed ID: 6541198
[TBL] [Abstract][Full Text] [Related]
19. Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin.
Cartel JL; Naudin JC
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):215-9. PubMed ID: 8046260
[TBL] [Abstract][Full Text] [Related]
20. [A new plan in the campaign against leprosy in Anjouan. Preliminary results].
Grillone S; Pattyn SR
Acta Leprol; 1986; 4(4):453-60. PubMed ID: 3296616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
